Purchases and Sales Made in Q4 2024 in Regeneron Pharmaceuticals, Inc. (REGN)
This table provides information about the institutional ownership of Regeneron Pharmaceuticals, Inc. (REGN) during Q4 2024. The information is specifically focused on institutions that hold shares of REGENERON PHARMACEUTICALS, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 12, 2025
Q4 2024
|
Wellington Management Group LLP
Boston, MA |
SELL
|
- |
-292K- 66.22% |
$205M - $305M
|
149K
$105M
|
|
|
Feb 13, 2025
Q4 2024
|
Invesco Ltd.
Atlanta, GA |
SELL
|
- |
-297K- 25.57% |
$208M - $311M
|
864K
$611M
|
|
|
Feb 12, 2025
Q4 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-430K- 5.74% |
$302M - $450M
|
7.06M
$4.99B
|
|
|
Feb 12, 2025
Q4 2024
|
Massachusetts Financial Services CO
Boston, MA |
SELL
|
- |
-499K- 97.04% |
$350M - $522M
|
15.2K
$10.8M
|
|
|
Jan 08, 2025
Q4 2024
|
International Assets Investment Management, LLC
Orlando, FL |
SELL
|
- |
-880K- 99.94% |
$618M - $922M
|
566
$400K
|
|
|
Feb 13, 2025
Q4 2024
|
Capital World Investors
Los Angeles, CA |
SELL
|
- |
-1.52M- 35.35% |
$1.07B - $1.59B
|
2.78M
$1.97B
|